Scientifically exceptional, deeply human
Learn more about the CCRM standard. Explore the science, expertise, and innovation that contribute to the CCRM Fertility network’s success rates.
One fully integrated network. Excellent outcomes.
We consistently achieve exceptional outcomes driven by rigorous protocols and data-driven results within the nation’s exclusive, fully integrated network of IVF, Genetics, and Research labs.
IVF Lab
Stringent clinical protocols, governance, innovation, and collaborative quality control between our IVF lab, Genetics, and Research teams translate to network-wide excellence and strong outcomes.
Genetics Lab
PGT-A is performed in our proprietary, in-network CCRM lab rather than through a third party, helping ensure consistency, quality control, and high confidence.
Research Lab
Translational-based research is conducted on-site in our Lone Tree, CO flagship to further the field of reproductive medicine, with clinical trials benefitting our entire CCRM network.
Built on science and data, powered by CCRM's top minds
Recognized by our peers, honored in our field
The breakthroughs advancing fertility care
CCRM Fertility has been at the forefront of reproductive science and research since our founding in 1987. Our team continues to innovate and improve outcomes for those who need our medical expertise to build their families.
Preimplantation genetic testing
In 2007, CCRM became the first to clinically test day 5 embryos (blastocysts) for all 23 pairs of human chromosomes in conjunction with a frozen embryo transfer, offering patients the best chance of reproductive success with the selection of a chromosomally normal blastocyst.
Embryo selection method
In 2024, CCRM Genetics published a ground-breaking prospective clinical study investigating how the embryo selection method impacts the likelihood of establishing a healthy pregnancy and live birth outcomes. Our results showed that choosing PGT-A (preimplantation genetic testing for aneuploidy) for embryo selection method at first IVF consult over standard embryo grading leads to a higher chance of reproductive success.
Current research that's shaping tomorrow's standard of care
Held to the highest industry standards
All CCRM labs are practicing clinics of the Society of Assisted Reproductive Technology (SART) and participate in multiple voluntary accreditation programs, ensuring rigorous quality control throughout the network.
CCRM is accredited with the College of American Pathologists (CAP) to ensure our quality, safety, and operational protocols, as well as the Clinical Laboratory Improvement Act (CLIA), which provides clinical accuracy in all diagnostic tests we perform.
We also comply with all FDA, CDC, and state-specific lab regulations.
“Our comprehensive research departments have published hundreds of abstracts at our major scientific meetings and peer review publications in many international journals. This research allows CCRM to offer patients the latest advancements in fertility care and optimal pregnancy outcomes.”
-Dr. William Schoolcraft, MD, HCLD
The team behind our clinical excellence
Under the long-standing direction of founder and industry pioneer Dr. William Schoolcraft is an exceptional group of clinical leaders. Their world-renowned expertise in reproductive medicine continues to set the industry standard.
Proven outcomes. Relentless innovation. Decades of leadership.
Because of our commitment to innovation and top-of-the-line science, CCRM attracts some of the best talent in reproductive medicine—fellows, reproductive endocrinologists, and embryologists—who help patients achieve their family-building goals in less time.
Impressive live birth rates
CCRM has exceptional SART success rates in every age category for women using their own eggs*. Our cutting-edge PGT-A* testing protocol — utilized in approximately 89% of our cycles — results in live birth rates up to 45% above the national average.**
Consistent innovation
CCRM continuously invests in our team, state-of-the-art facilities, cutting-edge technology, and groundbreaking research. We’re relentlessly committed to our craft, always striving for the best possible outcomes.
Long-standing leadership
Founded in 1987 by world-renowned Dr. William Schoolcraft, CCRM’s flagship location in Lone Tree, The Colorado Center for Reproductive Medicine, continues a legacy of clinical leadership. With more than 35 years of experience and continuing innovation, CCRM has helped families welcome more than 100,000 babies and counting.
Strong history of innovation and pioneering advancements
CCRM Fertility has a reputation of continuing innovation for more than 35 years. We commit ongoing resources toward groundbreaking research to keep pushing the envelope on the strongest outcomes for our patients.
1987
Colorado Center for Reproductive Medicine is founded by Dr. Schoolcraft
1990
First frozen embryo pregnancy and first donor egg-conceived baby born in Colorado
1993
Pioneer assisted hatching, driving significant improvements in IVF success rates
1996
Pioneer worldwide blastocyst culture with significant improvements to IVF success rates
2007
First worldwide clinical applications of preimplantation genetic testing of biopsied blastocysts for all 23 pairs of chromosomes followed by euploid frozen embryo transfer, resulting in significant improvements in live birth outcomes
2013
In partnership with Colorado State University, CCRM supports the nation’s first non-thesis Master’s Program to train the next generation of embryologists
2015
Successfully completes clinical trials on antioxidant intervention for improving ovarian function and reproductive success
2017
Launches donor egg bank to expand donor options for patients
2018
Initiates non-invasive PGT-A clinical study exclusive to CCRM
2019
Publishes groundbreaking research identifying the optimal histocompatibility matching of embryos for successful implantation
2020
Study identifies sperm and embryo epigenetic changes in older men tied to autism and neuro-developmental disorders
2021
Joins Unified Women’s Health Network
2021
2022
Develops a predictive risk model for early onset diminished ovarian reserve (DOR)
2023
Generates human blastoids for fertility research and initiates a clinical study on in vitro maturation (IVM)
2023
CCRM Genetics wins second place at the ASRM 2023 Scientific Congress Prize Paper competition and also wins the ASRM 2023 SRBT Prize Paper award
2024
CCRM Genetics wins third place at the ASRM 2024 Scientific Congress Prize Paper competition
2024
CCRM Genetics wins ASRM 2024 Reproductive Immunology (RISIG) Prize Paper award
*2007-2023 SART data
**Source: SART 2023 Preliminary Data; Note each market includes competitors within a 100-mile radius of CCRM’s clinic;
1. Success rates are based on singleton live births (% of transfers) weighted based on CCRM’s patient age mix
Get in touch
Ready to learn more? Submit your information and a member of our team will be in touch to discuss how a partnership with CCRM can benefit your patients.